462
We report a 59-year-old patient with chronic myeloid leukemia, who developed severe interstitial lung fibrosis after short term and sequential treatment with melphalan and busulfan.
 a 59-year-old patient with chronic myeloid leukemia: Subject; 59-year-old: Subject.Age; interstitial lung fibrosis: Effect; short term and sequential treatment with melphalan and busulfan: Treatment; chronic myeloid leukemia: Treatment.Disorder; short term: Treatment.Time_elapsed; melphalan: Treatment.Drug; busulfan: Treatment.Drug; melphalan: Combination.Drug; busulfan: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 59-year-old patient with chronic myeloid leukemia: Subject; 59-year-old: Subject.Age; interstitial lung fibrosis: Effect; short term and sequential treatment with melphalan and busulfan: Treatment; chronic myeloid leukemia: Treatment.Disorder; short term: Treatment.Time_elapsed; melphalan: Treatment.Drug; busulfan: Treatment.Drug; melphalan: Combination.Drug; busulfan: Combination.Drug